Oral candida species distribution in patients receiving radiotherapy for head and neck cancer

Abstract

Abstract: PURPOSE: To investigate the distribution of oral candida species in head and neck cancer (HNC) patients treated with radiation therapy, and provide the basis for planning of clinical preventive measures. METHODS: Saliva was sampled from 60 HNC patients before, during and after radiation. Concomitantly, 60 healthy individuals whose age and sex matched that of the patient group were selected as control group. Oral candida carriages were quantitatively detected and the different candida species were identified by multiple measures such as CHROMagar candida culture medium and API 20C AUX yeast identification system. Then the differences between the two groups in terms of the candida detection rate and the distribution of each species of candida were analyzed with SPSS 17.0 software package. RESULTS: Xerostomia and dysphagia was found in 54 HNC patients during radiotherapy, radiation-induced oral mucotitis(RIOM) was found in 50 HNC patients,and oral candidiasis was found in 18 HNC patients; In radiation group, the detection rate of candida colonization during radiation was 56.7%, 63.3% postradiation, which showed significant differences compared with pre-radiation (χ²=18.320,P<0.001 ); Among the 54 identified clinical isolates, candida albicans (n=42) was the most frequent, followed by candida parapsilosis (n=6), candida tropicalis (n=4) and candida glabrata (n=2). In radiation group, the oral candida pathogens detection rate was 30%, and candida colonization was 46.7%. CONCLUSIONS: The oral candida colonization rate was significantly higher in HNC patients after radiotherapy, which indicated that the candida infection may be closely related to RIOM.

Key words: Head and neck cancer, Radiotherapy, Oral mucositis, Oral candida

ZHANG Yuan-yuan, LI Ai-qin, WANG Ning-ning, LIU Li-na, CUI Ji-li. Oral candida species distribution in patients receiving radiotherapy for head and neck cancer[J]. Shanghai Journal of Stomatology, 2014, 23(5): 605-608.

References

[1] Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
[2] 谷铣之, 殷蔚伯, 刘泰福, 等. 肿瘤放射治疗学[M]. 北京：北京医科大学中国协和医科大学联合出版社, 1997: 356-365.
[3] Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology and consequences for patients[J]. Cancer,2004,100（9 suppl）: 1995-2025.
[4] 刘坤,高宁,王翼川,等.口腔癌术后放疗患者口腔菌群的变化[J]. 华西口腔医学杂志, 2005, 23(2): 128-135.
[5] Almståhl A, Wikström M, Fagerberg-Mohlin B. Microflora in oral ecosystems in subjects with radiation-induced hyposalivation [J]. Oral Dis, 2008, 14(6): 541-549.
[6] de Freitas EM, Nobre SA, Pires MB, et al. Oral Candida species in head and neck cancer patients treated by radiotherapy [J]. Auris Nasus Larynx, 2013, 40(4): 400-404.
[7] Candida albicans infection in patients with oral squamous cell carcinoma [J]. Vojonsanit Pregl, 2010, 67(9): 766-770.
[8] 徐岩英, 胡碧琼, 刘立新, 等. 含漱浓缩定量培养对OPC诊断价值的探讨 [J]. 中华口腔医学杂志, 1995, 30(5): 294.
[9] 陈谦明,周曾同.口腔黏膜病学[M].北京：人民卫生出版社, 2010: 33-37.
[10] Thaweboon S, Thaweboon B, Srithavai T, et al. Oral colonization of Candida species in patients receiving radiotherapy in the head and neck area [J]. Quintessence Int, 2008, 39(2): e52-57.
[11] Belazi M, Velegraki A, Koussidou-Eremondi T, et al. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment[J]. Oral Microbiol Immunol, 2004, 19(6): 347-351.
[12] Dambroso D, Svidzinski TIE, Svidzinski AE, et al. Radiotherapy effect on frequency of Candida spp. and on virulence of C. albicans isolated from the oral cavity of head and neck cancer patients [J]. J Basic Appl Pharm Sci, 2009, 30(2): 153-159.
[13] Redding SW, Zellars RC, Kirkpatrick WR, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer[J]. J Clin Microbiol, 1999, 37(12): 3896-3900.
[14] Ramirez-Amador V, Silverman S Jr, Mayer P, et al. Candida l colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997, 84(2): 149-153.
[15] Nicolatou-Galitis O, Dardoufas K, Markoulatos P, et al. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte macrophage colony-stimulating factor(GM-CSF) mouthwash [J]. J Oral Pathol Med, 2001, 30(8): 471-480.
[16] Dahiya MC, Redding SW, Dahiya RS, et al. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer [J]. Int J Radiat Oncol Biol Phys, 2003, 57(1): 79-83.
[17] Jham BC, França EC, Oliveira RR, et al. Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103(3): 355-358.
[18] 徐岩英,胡碧琼.口腔念珠菌及其致病性的研究 [J].中华口腔医学杂志,1997, 32(3): 180-182.
[19] Epstein JB, Pearsall NN, Truelove EL. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects [J]. J Clin Microbiol, 1980, 12(3): 475-476.
[20] Sanjaya PR, Gokul S, Gururaj Patil B, et al. Candida in oral pre-cancer and oral cancer[J]. Med Hypotheses,2011,77(6):1125-1128.
[21] Redding SW, Dahiya MC, Kirkpatrick WR, et al. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2004,97(1):47-52.
[22] Leung WK, Dassanayake RS, Yau JY, et al. Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors [J]. J Clin Microbiol, 2000, 38(6): 2219-2226.